Altered subcellular location of phosphorylated Smads in Alzheimer's disease

European Journal of Neuroscience

Volumn 24, Issue 8, 2006, Pages 2327-2334

  Ueberham, Uwe ^a   Ueberham, Elke ^a   Gruschka, Hildegard ^a   Arendt, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer's disease; Cytoplasmic granules; Human hippocampus; Neurofibrillary tangles; Smad2; Smad3

Indexed keywords

AMYLOID; SMAD2 PROTEIN; SMAD3 PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN; CELL GRANULE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; NERVE CELL; NEUROFIBRILLARY TANGLE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PYRAMIDAL NERVE CELL;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; BRAIN CHEMISTRY; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEUROFIBRILLARY TANGLES; PHOSPHORYLATION; SENILE PLAQUES; SMAD PROTEINS; SMAD2 PROTEIN; SMAD3 PROTEIN; SUBCELLULAR FRACTIONS;

EID: 33750320547     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2006.05109.x     Document Type: Article

References (63)

1. Abdollah, S., Macias-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L. & Wrana, J.L. (1997) TbetaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem., 272, 27678-27685.
2. Arendt, T. (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. Prog. Neurobiol., 71, 83-248.
3. Arendt, T., Holzer, M., Grossmann, A., Zedlick, D. & Bruckner, M.K. (1995) Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease. Neuroscience, 68, 5-18.
4. Bottner, M., Unsicker, K. & Suter-Crazzolara, C. (1996) Expression of TGF-beta type II receptor mRNA in the CNS. Neuroreport, 7, 2903-2907.
5. Braak, H. & Braak, E. (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. (Berl.), 82, 239-259.
6. Burton, T., Liang, B., Dibrov, A. & Amara, F. (2002) Transforming growth factor-beta-induced transcription of the Alzheimer beta-amyloid precursor protein gene involves interaction between the CTCF-complex and Smads. Biochem. Biophys. Res. Commun., 295, 713-723.
7. Cataldo, A.M., Petanceska, S., Terio, N.B., Peterhoff, C.M., Durham, R., Mercken, M., Mehta, P.D., Buxbaum, J., Haroutunian, V. & Nixon, R.A. (2004) Abeta localization in abnormal endosomes: association with earliest Abeta elevations in AD and Down syndrome. Neurobiol. Aging, 25, 1263-1272.
8. Chacko, B.M., Qin, B., Correia, J.J., Lam, S.S., de Caestecker, M.P. & Lin, K. (2001) The L3 loop and C-terminal phosphorylation jointly define Smad protein trimerization. Nat. Struct. Biol., 8, 248-253.
9. Dennler, S., Huet, S. & Gauthier, J.M. (1999) A short amino-acid sequence in MH1 domain is responsible for functional differences between Smad2 and Smad3. Oncogene, 18, 1643-1648.
10. Derynck, R., Akhurst, R.J. & Balmain, A. (2001) TGF-beta signaling in tumor suppression and cancer progression. Nat. Genet., 29, 117-129.
11. ten Dijke, P., Goumans, M.J., Itoh, F. & Itoh, S. (2002) Regulation of cell proliferation by Smad proteins. J. Cell Physiol., 191, 1-16.
12. ten Dijke, P. & Hill, C.S. (2004) New insights into TGF-beta-Smad signalling. Trends Biochem. Sci., 29, 265-273.
13. Docagne, F., Gabriel, C., Lebeurrier, N., Lesne, S., Hommet, Y., Plawinski, L., MacKenzie, E.T. & Vivien, D. (2004) Sp1 and Smad transcription factors cooperate to mediate TGF-beta-dependent activation of amyloid-beta precursor protein gene transcription. Biochem. J., 383, 393-399.
14. Dong, C., Li, Z., Alvarez, R. Jr, Feng, X.H. & Goldschmidt-Clermont, P.J. (2000) Microtubule binding to Smads may regulate TGF beta activity. Mol. Cell, 5, 27-34.
15. Ellgaard, L. & Ruddock, L.W. (2005) The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Report, 6, 28-32.
16. Flanders, K.C., Kim, E.S. & Roberts, A.B. (2001) Immunohistochemical expression of Smads 1-6 in the 15-day gestation mouse embryo: signaling by BMPs and TGF-betas. Dev. Dyn., 220, 141-154.
17. Fukuchi, M., Imamura, T., Chiba, T., Ebisawa, T., Kawabata, M., Tanaka, K. & Miyazono, K. (2001) Ligand-dependent degradation of Smad3 by a ubiquitin ligase complex of ROC1 and associated proteins. Mol. Biol. Cell, 12, 1431-1443.
18. Gagnon, E., Duclos, S., Rondeau, C., Chevet, E., Cameron, P.H., Steele-Mortimer, O., Paiement, J., Bergeron, J.J. & Desjardins, M. (2002) Endoplasmic reticulum-mediated phagocytosis is a mechanism of entry into macrophages. Cell, 110, 119-131.
19. Gartner, U., Holzer, M., Heumann, R. & Arendt, T. (1995) Induction of p21ras in Alzheimer pathology. Neuroreport, 6, 1441-1444.
20. Goumans, M.J. & Mummery, C. (2000) Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice. Int. J. Dev. Biol., 44, 253-265.
21. Greenberg, S.G., Davies, P., Schein, J.D. & Binder, L.I. (1992) Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau. J. Biol. Chem., 267, 564-569.
22. Hardy, J.A., Wester, P., Winblad, B., Gezelius, C., Bring, G. & Eriksson, A. (1985) The patients dying after long terminal phase have acidotic brains; implications for biochemical measurements on autopsy tissue. J. Neural Transm., 61, 253-264.
23. Hayes, S., Chawla, A. & Corvera, S. (2002) TGF beta receptor internalization into EEA1-enriched early endosomes: role in signaling to Smad2. J. Cell Biol., 158, 1239-1249.
24. Javelaud, D. & Mauviel, A. (2005) Crosstalk mechanisms between the mitogen-activated protein kinase pathways and Smad signaling downstream of TGF-beta: implications for carcinogenesis. Oncogene, 24, 5742-5750.
25. Kfir, S., Ehrlich, M., Goldshmid, A., Liu, X., Kloog, Y. & Henis, Y.I. (2005) Pathway- and expression level-dependent effects of oncogenic N-Ras: p27 (Kip1) mislocalization by the Ral-GEF pathway and Erk-mediated interference with Smad signaling. Mol. Cell Biol., 25, 8239-8250.
26. Konig, H.G., Kogel, D., Rami, A. & Prehn, J.H. (2005) TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling. J. Cell Biol., 168, 1077-1086.
27. Kretzschmar, M., Doody, J., Timokhina, I. & Massague, J. (1999) A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras. Genes Dev., 13, 804-816.
28. Kurisaki, A., Kose, S., Yoneda, Y., Heldin, C.H. & Moustakas, A. (2001) Transforming growth factor-beta induces nuclear import of Smad3 in an importin-beta1 and Ran-dependent manner. Mol. Biol. Cell, 12, 1079-1091.
29. Labbe, E., Silvestri, C., Hoodless, P.A., Wrana, J.L. & Attisano, L. (1998) Smad2 and Smad3 positively and negatively regulate TGF beta-dependent transcription through the forkhead DNA-binding protein FAST2. Mol. Cell, 2, 109-120.
30. Lee, J., Fukumoto, H., Orne, J., Klucken, J., Raju, S., Vanderburg, C.R., Irizarry, M.C., Hyman, B.T. & Ingelsson, M. (2005) Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms. Exp. Neurol., 194, 91-96.
31. Lin, X., Duan, X., Liang, Y.Y., Su, Y., Wrighton, K.H., Long, J., Hu, M., Davis, C.M., Wang, J., Brunicardi, F.C., Shi, Y., Chen, Y.G., Meng, A. & Feng, X.H. (2006) PPM1A functions as a Smad phosphatase to terminate TGFbeta signaling. Cell, 125, 915-928.
32. Lin, A.H., Luo, J., Mondshein, L.H., ten Dijke, P., Vivien, D., Contag, C.H. & Wyss-Coray, T. (2005) Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. J. Immunol., 175, 547-554.
33. Liu, X., Sun, Y., Constantinescu, S.N., Karam, E., Weinberg, R.A. & Lodish, H.F. (1997) Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. Proc. Natl Acad. Sci. USA, 94, 10669-10674.
34. Lo, R.S. & Massague, J. (1999) Ubiquitin-dependent degradation of TGF-beta-activated smad2. Nat. Cell Biol., 1, 472-478.
35. Lu, J., Wu, Y., Sousa, N. & Almeida, O.F. (2005) SMAD pathway mediation of BDNF and TGFbeta2 regulation of proliferation and differentiation of hippocampal granule neurons. Development, 132, 3231-3242.
36. Luo, Q., Nieves, E., Kzhyshkowska, J. & Angeletti, R.H. (2006) Endogenous TGF-beta receptor-mediated smad signaling complexes analyzed by mass spectrometry. Mol. Cell Proteomics, 5, 1245-1260.
37. Massague, J., Blain, S.W. & Lo, R.S. (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 103, 295-309.
38. Matsuura, I., Denissova, N.G., Wang, G., He, D., Long, J. & Liu, F. (2004) Cyclin-dependent kinases regulate the antiproliferative function of Smads. Nature, 430, 226-231.
39. Metuzals, J., Robitaille, Y., Houghton, S., Gauthier, S. & Leblanc, R. (1988) Paired helical filaments and the cytoplasmic-nuclear interface in Alzheimer's disease. J. Neurocytol., 17, 827-833.
40. Monfort, J.C., Javoy-Agid, F., Hauw, J.J., Dubois, B. & Agid, Y. (1985) Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain, 108, 301-313.
41. Penheiter, S.G., Mitchell, H., Garamszegi, N., Edens, M., Dore, J.J. Jr & Leof, E.B. (2002) Internalization-dependent and - independent requirements for transforming growth factor beta receptor signaling via the Smad pathway. Mol. Cell Biol., 22, 4750-4759.
42. Piek, E., Ju, W.J., Heyer, J., Escalante-Alcalde, D., Stewart, C.L., Weinstein, M., Deng, C., Kucherlapati, R., Bottinger, E.P. & Roberts, A.B. (2001) Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem., 276, 19945-19953.
43. Preece, P. & Cairns, N.J. (2003) Quantifying mRNA in postmortem human brain: influence of gender, age at death, postmortem interval, brain pH, agonal state and inter-lobe mRNA variance. Brain Res. Mol. Brain Res., 118, 60-71.
44. Runyan, C.E., Schnaper, H.W. & Poncelet, A.C. (2005) The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J. Biol. Chem., 280, 8300-8308.
45. Sasaki, A., Masuda, Y., Ohta, Y., Ikeda, K. & Watanabe, K. (2001) Filamin associates with Smads and regulates transforming growth factor-beta signaling. J. Biol. Chem., 276, 17871-17877.
46. Sheffield, L.G., Miskiewicz, H.B., Tannenbaum, L.B. & Mirra, S.S. (2006) Nuclear pore complex proteins in Alzheimer disease. J. Neuropathol. Exp. Neurol., 65, 45-54.
47. Shoji, H., Tsuchida, K., Kishi, H., Yamakawa, N., Matsuzaki, T., Liu, Z., Nakamura, T. & Sugino, H. (2000) Identification and characterization of a PDZ. protein that interacts with activin type II receptors. J. Biol. Chem., 275, 5485-5492.
48. Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P. & Heldin, C.H. (1997) Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem., 272, 28107-28115.
49. Sousa Lopes, S.M., van den Carvalho, R.L.D.S., Goumans, M.J., ten Dijke, P. & Mummery, C.L. (2003) Distribution of phosphorylated Smad2 identifies target tissues of TGF beta ligands in mouse development. Gene Expr. Patterns, 3, 355-360.
50. Tarkowski, E., Issa, R., Sjogren, M., Wallin, A., Blennow, K., Tarkowski, A. & Kumar, P. (2002) Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol. Aging, 23, 237-243.
51. Touret, N., Paroutis, P. & Grinstein, S. (2005) The nature of the phagosomal membrane: endoplasmic reticulum versus plasmalemma. J. Leukoc. Biol., 77, 878-885.
52. Ueberham, U., Ueberham, E., Gruschka, H. & Arendt, T. (2003) Connective tissue growth factor in Alzheimer's disease. Neuroscience, 116, 1-6.
53. Vawter, M.P., Dillon-Carter, O., Tourtellotte, W.W., Carvey, P. & Freed, W.J. (1996) TGFbeta1 and TGFbeta2 concentrations are elevated in Parkinson's disease in ventricular cerebrospinal fluid. Exp. Neurol., 142, 313-322.
54. Vincent, I., Pae, C.I. & Hallows, J.L. (2003) The cell cycle and human neurodegenerative disease. Prog. Cell Cycle Res., 5, 31-41.
55. van der Wal, E.A., Gomez-Pinilla, F. & Cotman, C.W. (1993) Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport, 4, 69-72.
56. Walter, J., Fluhrer, R., Hartung, B., Willem, M., Kaether, C., Capell, A., Lammich, S., Multhaup, G. & Haass, C. (2001) Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem., 276, 14634-14641.
57. Worman, H.J. (2006) Inner nuclear membrane and regulation of Smad-mediated signaling. Biochim. Biophys. Acta, 1761, 626-631.
58. Wu, J.W., Fairman, R., Penry, J. & Shi, Y. (2001) Formation of a stable heterodimer between Smad2 and Smad4. J. Biol. Chem., 276, 20688-20694.
59. Wyss-Coray, T., Masliah, E., Mallory, M., McConlogue, L., Johnson-Wood, K., Lin, C. & Mucke, L. (1997) Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer's disease. Nature, 389, 603-606.
60. Xiao, Z., Liu, X. & Lodish, H.F. (2000) Importin beta mediates nuclear translocation of Smad 3. J. Biol. Chem., 275, 23425-23428.
61. Xu, L., Alarcon, C., Col, S. & Massague, J. (2003) Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. J. Biol. Chem., 278, 42569-42577.
62. Xu, L., Kang, Y., Col, S. & Massague, J. (2002) Smad2 nucleocytoplasmic shuttling by nucleoporins CAN/Nup214 and Nup153 feeds TGFbeta signaling complexes in the cytoplasm and nucleus. Mol. Cell, 10, 271-282.
63. Zetterberg, H., Andreasen, N. & Blennow, K. (2004) Increased cerebrospinal fluid levels of transforming growth factor-beta1 in Alzheimer's disease. Neurosci. Lett., 367, 194-196.